Receive updates from Patient Advocates and MS specialists sent directly to your inbox.

Sign up now


Lift MS® is designed to educate and motivate patients and Care Partners living with relapsing MS. There are many ways to join this inspiring online community:

You can also make a 1-on-1 connection through Teva’s MS Peer* Program.

Ever wish you could talk to someone who knows what it’s like to live with relapsing MS the way you do? No matter how long it’s been since you were diagnosed, talking to an MS Peer can make all the difference in how you manage your therapy, set expectations and feel about your diagnosis.

To find the right MS Peer match for you, request an MS Peer now by answering a few questions. You’ll be connected with someone whose interests, stage of life and therapy experience are most relevant to yours.

*MS Peers are compensated by Teva.

What is Lift MS®?

The Lift MS® Blog helps raise awareness for the relapsing MS community by empowering people. Through information, motivation and opportunities for action, you’ll discover the lift you’re looking for to live with MS, whether you’re a patient, Care Partner or supportive friend.

Lift MS® Blog

Register now to receive updates from the Lift MS® Blog.

Find the lift you’re looking for, with a community of people who can relate.

If you’re living with relapsing MS, you’re not alone. Join the thousands of people who make up the Lift MS® community on Facebook for ongoing support and inspiration. From tips and tricks to easy, MS-friendly recipes and MS patient stories, there’s no shortage of uplifting moments to encourage you.

Lift MS® Blog

Visit us on Facebook to join the conversation.


COPAXONE® (glatiramer acetate injection) is prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS).

Important Safety Information

Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol.

Some patients report a short-term reaction right after or within minutes after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain, fast heart beat, anxiety, and trouble breathing. These symptoms generally appear within seconds to minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.

Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense.

A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

The most common side effects of COPAXONE® include redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

Please see full Prescribing Information for Teva's COPAXONE®.

Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.

autoject®2 for glass syringe is a registered trademark of Owen Mumford, Ltd. Available by prescription only.
Apple is a registered trademark of Apple Inc. App Store is a service mark of Apple Inc.
Google Play and the Google Play logo are trademarks of Google LLC.

You are about to leave and enter a website operated by a third party.

Would you like to continue?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?